Annual Working Capital
-$33.52 M
-$31.04 M-1249.64%
31 December 2023
Summary:
Seelos Therapeutics annual working capital is currently -$33.52 million, with the most recent change of -$31.04 million (-1249.64%) on 31 December 2023. During the last 3 years, it has fallen by -$43.59 million (-433.08%). SEEL annual working capital is now -144.60% below its all-time high of $75.17 million, reached on 31 December 2021.SEEL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
-$28.18 M
+$4.99 M+15.03%
30 June 2024
Summary:
Seelos Therapeutics quarterly working capital is currently -$28.18 million, with the most recent change of +$4.99 million (+15.03%) on 30 June 2024. Over the past year, it has increased by +$959.00 thousand (+3.29%). SEEL quarterly working capital is now -134.10% below its all-time high of $82.65 million, reached on 30 June 2021.SEEL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SEEL Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1249.6% | +3.3% |
| 3 y3 years | -433.1% | -138.7% |
| 5 y5 years | -1434.1% | -364.0% |
SEEL Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -144.6% | at low | -137.5% | +36.3% |
| 5 y | 5 years | -144.6% | at low | -134.1% | +36.3% |
| alltime | all time | -144.6% | at low | -134.1% | +36.3% |
Seelos Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -$28.18 M(-15.0%) |
| Mar 2024 | - | -$33.17 M(-1.1%) |
| Dec 2023 | -$33.52 M(+1249.6%) | -$33.52 M(+15.1%) |
| Sept 2023 | - | -$29.14 M(-34.2%) |
| June 2023 | - | -$44.27 M(+183.5%) |
| Mar 2023 | - | -$15.62 M(+528.7%) |
| Dec 2022 | -$2.48 M(-103.3%) | -$2.48 M(-113.3%) |
| Sept 2022 | - | $18.62 M(-51.0%) |
| June 2022 | - | $38.03 M(-37.2%) |
| Mar 2022 | - | $60.54 M(-19.5%) |
| Dec 2021 | $75.17 M(+646.9%) | $75.17 M(+3.2%) |
| Sept 2021 | - | $72.86 M(-11.8%) |
| June 2021 | - | $82.65 M(+195.6%) |
| Mar 2021 | - | $27.96 M(+177.8%) |
| Dec 2020 | $10.06 M(+3065.1%) | $10.06 M(+43.0%) |
| Sept 2020 | - | $7.04 M(+73.6%) |
| June 2020 | - | $4.05 M(-41.8%) |
| Mar 2020 | - | $6.96 M(+2090.3%) |
| Dec 2019 | $318.00 K(-87.3%) | $318.00 K(-97.0%) |
| Sept 2019 | - | $10.67 M(+117.2%) |
| June 2019 | - | $4.92 M(+63.1%) |
| Mar 2019 | - | $3.01 M(+19.9%) |
| Dec 2018 | $2.51 M(-49.8%) | $2.51 M(-38.0%) |
| Sept 2018 | - | $4.06 M(-22.4%) |
| June 2018 | - | $5.23 M(+23.6%) |
| Mar 2018 | - | $4.23 M(-15.6%) |
| Dec 2017 | $5.01 M(-165.4%) | $5.01 M(-27.1%) |
| Sept 2017 | - | $6.87 M(+1.0%) |
| June 2017 | - | $6.80 M(+166.2%) |
| Mar 2017 | - | $2.56 M(-133.4%) |
| Dec 2016 | -$7.66 M(-19.1%) | -$7.66 M(+42.6%) |
| Sept 2016 | - | -$5.37 M(-35.6%) |
| June 2016 | - | -$8.34 M(+102.0%) |
| Mar 2016 | - | -$4.13 M(-56.4%) |
| Dec 2015 | -$9.47 M(-248.3%) | -$9.47 M(-822.7%) |
| Sept 2015 | - | $1.31 M(-72.9%) |
| June 2015 | - | $4.84 M(-55.5%) |
| Mar 2015 | - | $10.88 M(+70.4%) |
| Dec 2014 | $6.38 M(-39.2%) | $6.38 M(-46.7%) |
| Sept 2014 | - | $11.98 M(+1.0%) |
| June 2014 | - | $11.86 M(+32.4%) |
| Mar 2014 | - | $8.96 M(-14.7%) |
| Dec 2013 | $10.50 M(+3.7%) | $10.50 M(-20.8%) |
| Sept 2013 | - | $13.26 M(-13.4%) |
| June 2013 | - | $15.31 M(+182.9%) |
| Mar 2013 | - | $5.41 M(-46.5%) |
| Dec 2012 | $10.13 M(-653.8%) | $10.13 M(-15.4%) |
| Sept 2012 | - | $11.97 M(+34.9%) |
| June 2012 | - | $8.87 M(-33.0%) |
| Mar 2012 | - | $13.23 M(-823.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | -$1.83 M(-122.4%) | -$1.83 M(-128.3%) |
| Sept 2011 | - | $6.46 M(+13.7%) |
| June 2011 | - | $5.68 M(-36.0%) |
| Mar 2011 | - | $8.88 M(+8.8%) |
| Dec 2010 | $8.16 M(-165.8%) | $8.16 M(+634.1%) |
| Sept 2010 | - | $1.11 M(-59.7%) |
| June 2010 | - | $2.76 M(-131.6%) |
| Mar 2010 | - | -$8.74 M(-29.6%) |
| Dec 2009 | -$12.41 M(-902.1%) | -$12.41 M(-1136.5%) |
| Sept 2009 | - | $1.20 M(-38.3%) |
| June 2009 | - | $1.94 M(-37.2%) |
| Mar 2009 | - | $3.09 M(+99.9%) |
| Dec 2008 | $1.55 M(+14.4%) | $1.55 M(-288.0%) |
| Sept 2008 | - | -$822.90 K(-149.0%) |
| June 2008 | - | $1.68 M(+587.1%) |
| Mar 2008 | - | $244.60 K(-81.9%) |
| Dec 2007 | $1.35 M(-73.4%) | $1.35 M(+182.2%) |
| Sept 2007 | - | $479.10 K(-77.9%) |
| June 2007 | - | $2.17 M(-41.2%) |
| Mar 2007 | - | $3.69 M(-27.4%) |
| Dec 2006 | $5.07 M(-245.7%) | $5.07 M(-320.3%) |
| Sept 2006 | - | -$2.30 M(+117.8%) |
| June 2006 | - | -$1.06 M(-145.9%) |
| Mar 2006 | - | $2.30 M(-166.1%) |
| Dec 2005 | -$3.48 M(-141.2%) | -$3.48 M(-227.6%) |
| Sept 2005 | - | $2.73 M(-33.5%) |
| June 2005 | - | $4.11 M(+4.6%) |
| Mar 2005 | - | $3.93 M(-53.6%) |
| Dec 2004 | $8.46 M(-10.3%) | $8.46 M(+55.8%) |
| Sept 2004 | - | $5.43 M(-42.0%) |
| June 2004 | - | $9.36 M(+64.5%) |
| Mar 2004 | - | $5.69 M(-39.7%) |
| Dec 2003 | $9.44 M(-393.7%) | $9.44 M(+29.9%) |
| Sept 2003 | - | $7.26 M(-1868.8%) |
| June 2003 | - | -$410.60 K(-91.0%) |
| Mar 2003 | - | -$4.58 M(+42.7%) |
| Dec 2002 | -$3.21 M(-118.7%) | -$3.21 M(-167.4%) |
| Sept 2002 | - | $4.77 M(-58.8%) |
| June 2002 | - | $11.58 M(+19.8%) |
| Mar 2002 | - | $9.66 M(-43.6%) |
| Dec 2001 | $17.14 M(-51.5%) | $17.14 M(-30.1%) |
| Sept 2001 | - | $24.53 M(-11.3%) |
| June 2001 | - | $27.65 M(-13.2%) |
| Mar 2001 | - | $31.86 M(-9.9%) |
| Dec 2000 | $35.35 M(+435.6%) | $35.35 M(-13.0%) |
| Sept 2000 | - | $40.65 M(+128.0%) |
| June 2000 | - | $17.83 M(+56.0%) |
| Mar 2000 | - | $11.43 M |
| Dec 1999 | $6.60 M(-315.9%) | - |
| Dec 1997 | -$3.06 M | - |
FAQ
- What is Seelos Therapeutics annual working capital?
- What is the all time high annual working capital for Seelos Therapeutics?
- What is Seelos Therapeutics annual working capital year-on-year change?
- What is Seelos Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly working capital year-on-year change?
What is Seelos Therapeutics annual working capital?
The current annual working capital of SEEL is -$33.52 M
What is the all time high annual working capital for Seelos Therapeutics?
Seelos Therapeutics all-time high annual working capital is $75.17 M
What is Seelos Therapeutics annual working capital year-on-year change?
Over the past year, SEEL annual working capital has changed by -$31.04 M (-1249.64%)
What is Seelos Therapeutics quarterly working capital?
The current quarterly working capital of SEEL is -$28.18 M
What is the all time high quarterly working capital for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly working capital is $82.65 M
What is Seelos Therapeutics quarterly working capital year-on-year change?
Over the past year, SEEL quarterly working capital has changed by +$959.00 K (+3.29%)